OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
August 23, 2019
A biosimilar to Eli Lilly’s Forsteo, biosimilar teriparatide, has been launched across Europe by Gedeon Richter following the patent expiration of the reference product.
August 22, 2019
Marchesini Group’s Compact 12 electronic counter with HarleNIR vision system measures product and active ingredient when filling and capping bottles for tablets and capsules.
August 21, 2019
Regulatory, cultural, and technical differences between drug and device development can pose challenges to pharmaceutical combination product development.
August 15, 2019
The latest research from GlobalData has revealed that more than two-thirds (69%) of CMOs high-containment facilities are based in the top five European Union countries and Switzerland.
The European Commission has approved an extension of the use of Dupixent (dupilumab) within the EU to include patients aged 12 to 17 years old with moderate-to-severe atopic dermatitis.
August 02, 2019
Homogeneity of the powder blend is crucial for solid-dosage drug manufacturing.
Complex and potent molecules demand greater technical and regulatory expertise to ensure safe handling.
Glass vials have come a long way from mere commodities and are now considered an integral part of final drug product.
Formulators of parenteral drugs must be cautious of specific considerations and challenges that arise during development and manufacture.
As patient-centered therapies and clinical trials become more important, innovation is providing more control and transparency in the way that pharmaceuticals are delivered.